JAB-BX200

N/A

Report date: 2022/03/23 17:37:01

Base Information

Drug NameJAB-BX200
Drug Alias NameJAB-BX200
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Ectonucleoside triphosphate diphosphohydrolase 1
TargetsEctonucleoside triphosphate diphosphohydrolase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJacobio Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A